Injective (INJ)

Repping Injective from Vietnam 🇻🇳

100 $INJ Squad Challenge https://t.co/Zwfpc5UPJG

I still think a lot of people are underestimating what Injective is building.

While the market keeps moving from one narrative to the next, Injective has stayed focused on one thing from the start: onchain finance.

Lately, it's been hard to ignore the progress.
Native USDC is live, making liquidity movement across ecosystems much smoother and reducing reliance on bridged assets.

The buyback mechanism has been interesting to watch too. As ecosystem activity grows, revenue continues flowing back into INJ buybacks, creating a direct link between network usage and supply reduction.

Builder activity also seems to be picking up. More teams are launching trading infrastructure, AI-powered tools, and financial applications across the ecosystem.

Then you look at what's already live:

• Sub-second finality
• Onchain orderbooks
• Tokenized assets and RWAs
• Regulated INJ futures in the U.S.
• Cross-chain liquidity and native USDC

To me, it feels like Injective is playing a different game.
Instead of chasing every

If you're wondering whether it's too late to short, focus on the top gainers this week after they break down below their daily ranges. They will catch up to BTC and other Alts! You'll get a better entry point instead of chasing those that already dumped!